Ana Ramirez Tovar
Biographic Data
| ID | 8262929 |
|---|---|
| NAME | Ana Ramirez Tovar |
| GIVEN NAMES | Ana Ramirez |
| FAMILY NAME | Tovar |
| SIGNATURE | TOVAR A R |
| AFFILIATIONS | Emory University |
| ORCID | 0000-0002-9038-6589 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)
Metabolic-dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease in children in the US and, if untreated, may progress to end-stage liver disease. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown improvement in MASLD markers in adults with type 2 diabetes mellitus (T2DM). Currently, there is a lack of medications available for the treatment of pediatric MASLD. We aimed to provide preliminary data o…
No prominent works on this page.
Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)
Metabolic-dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease in children in the US and, if untreated, may progress to end-stage liver disease. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown improvement in MASLD markers in adults with type 2 diabetes mellitus (T2DM). Currently, there is a lack of medications available for the treatment of pediatric MASLD. We aimed to provide preliminary data o…
Alanine aminotransferase (1 work) · Diabetes mellitus (1 work) · Diabetes Treatment and Management (1 work) · Endocrinology (1 work) · Gastroenterology (1 work) · Glucagon (1 work) · Glucagon receptor (1 work) · Insulin (1 work) · Internal Medicine (1 work) · Liver disease (1 work)